Stanford Blood Center Receives FDA Approval to Distribute Licensed COVID-19 Convalescent Plasma NationwidePALO ALTO, Calif. — October 15, 2025 — Stanford Blood Center (SBC) has received approval from the U.S. Food and Drug Administration (FDA) for national distribution of COVID-19 Convalescent Plasma (CCP) for the treatment of immunocompromised patients, making